Anfibatide

DB15094InvestigationalProtein Based Therapies

Anfibatide is under investigation in clinical trial NCT01585259 (Anfibatide Phase Ib-IIa Clinical Trial).

Mechanism: Pharmacologically active on Platelet glycoprotein Ib alpha chain
Curator reviewed

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Anfibatide, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.